We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03783078
Brief Title: Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

First Submitted : December 19, 2018
First Submitted that Met QC Criteria : December 19, 2018
First Posted : December 20, 2018

Last Update Submitted that Met QC Criteria : November 30, 2022
Last Update Posted : December 1, 2022